Case Report

Published on 08 Aug 2022

Case report: Unusual coexistence between familial hypercholesterolemia and familial hypobetalipoproteinemia

in Lipids in Cardiovascular Disease

Kei Sasaki
Hayato Tada
Masa-aki Kawashiri
Toshimitsu Ito

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.942772

1,695 views
1 citation

Study Protocol

Published on 04 Aug 2022

Treatment patterns and use of healthcare resources of patients with atherosclerotic cardiovascular disease and hypercholesterolemia and patients with familial hypercholesterolemia in Spain: Protocol of the Reality study

in Lipids in Cardiovascular Disease

Vivencio Barrios
Mar Castellanos
Raquel Campuzano Ruiz
Jorge Francisco Gómez Cerezo
Isabel Egocheaga Cabello
José M. Gámez
Icíar Martínez López
José María Mostaza
Nuria Morant Talamante
Javier Parrondo

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.966049

3,401 views
6 citations

Original Research

Published on 27 Jul 2022

The relationship of remnant cholesterol and abdominal obesity in children: A cross-sectional study

in Lipids in Cardiovascular Disease

Jishuang Tong
Xinggui Li
Xiaoyue Liang
Fang Tang
Yanling Ren
Guang Hao
Xin Peng
Sunqing Luo
Ye Feng
Daochao Huang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.929560

1,821 views
3 citations

Original Research

Published on 26 Jul 2022

Trajectory of low-density lipoprotein cholesterol in patients with chronic kidney disease and its association with cardiovascular disease

in Lipids in Cardiovascular Disease

Shih-Wei Wang
Lung-Chih Li
Chung-Ming Fu
Yueh-Ting Lee
Hsiao-Ching Kuo
Chien-Ning Hsu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.887915

2,388 views
1 citation

Original Research

Published on 26 Jul 2022

An intensive, structured, mobile devices-based healthcare intervention to optimize the lipid-lowering therapy improves lipid control after an acute coronary syndrome

in Lipids in Cardiovascular Disease

Sonia Ruiz-Bustillo
Neus Badosa
Ignacio Cabrera-Aguilera
Consol Ivern
Marc Llagostera
Diana Mojón
Miren Vicente
Núria Ribas
Lluis Recasens
Julio Martí-Almor

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.916031

1,695 views

Original Research

Published on 15 Jul 2022

Optimized Treatment of Refractory Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia With Alirocumab (OPTIMIZE)

in Lipids in Cardiovascular Disease

Isabella Sudano
Francois Mach
Tiziano Moccetti
Thilo Burkard
Christian Fahe
Alain Delabays
Hans Rickli
Pierre-Frédéric Keller
Jörn Dopheide
Sereina Bodenmann

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.953040

2,485 views

Editorial

Published on 15 Jul 2022

Editorial: Insights in lipids in cardiovascular disease: 2021

in Lipids in Cardiovascular Disease

Irena Levitan
Tomas Vaisar

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.940153

1,325 views

Methods

Published on 14 Jul 2022

Using Synthetic ApoC-II Peptides and nAngptl4 Fragments to Measure Lipoprotein Lipase Activity in Radiometric and Fluorescent Assays

in Lipids in Cardiovascular Disease

Dean Oldham
Hong Wang
Juliet Mullen
Emma Lietzke
Kayla Sprenger
Philip Reigan
Robert H. Eckel
Kimberley D. Bruce

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.926631

3,195 views
7 citations

Original Research

Published on 11 Jul 2022

Antiphospholipid Syndrome-Related Pulmonary Embolism: Clinical Characteristics and Early Recognition

in Lipids in Cardiovascular Disease

Maojing Shi
Weibo Gao
Yuebo Jin
Jihong Zhu
Yuansheng Liu
Tianbing Wang
Chun Li

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.872523

5,309 views
5 citations

Original Research

Published on 07 Jul 2022

Dyslipidemia and the Prevalence of Hypertension: A Cross-Sectional Study Based on Chinese Adults Without Type 2 Diabetes Mellitus

in Lipids in Cardiovascular Disease

Wenke Cheng
Jingqi Zhuang
Siwei Chen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.938363

4,777 views
6 citations

Original Research

Published on 07 Jul 2022

U-Shaped Relationship of Non-HDL Cholesterol With All-Cause and Cardiovascular Mortality in Men Without Statin Therapy

in Lipids in Cardiovascular Disease

Rui-Xiang Zeng
Jun-Peng Xu
Yong-Jie Kong
Jia-Wei Tan
Li-Heng Guo
Min-Zhou Zhang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.903481

4,032 views
8 citations

Original Research

Published on 06 Jul 2022

Corrected Serum Ionized Calcium as a Risk Factor Related to Adult Dyslipidemia

in Lipids in Cardiovascular Disease

Ke Yun
Shuang Zhang
Xiaotao Yang
Dongliang Man
Jialiang Yao
Wei Wang
Xiaoxu Han

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.916991

2,015 views
2 citations

Original Research

Published on 05 Jul 2022

Risk Factors and Outcomes of Acute Myocardial Infarction in a Cohort of Antiphospholipid Syndrome

in Lipids in Cardiovascular Disease

Yuzhou Gan
Yawei Zhao
Gongming Li
Hua Ye
Yunshan Zhou
Chang Hou
Lan Wang
Jianping Guo
Chun Li

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.871011

2,686 views
2 citations

Original Research

Published on 05 Jul 2022

Vascular Age, Metabolic Panel, Cardiovascular Risk and Inflammaging in Patients With Rheumatoid Arthritis Compared With Patients With Osteoarthritis

in Lipids in Cardiovascular Disease

Gabriel-Santiago Rodríguez-Vargas
Pedro Santos-Moreno
Jaime-Andrés Rubio-Rubio
Paula-Katherine Bautista-Niño
Darío Echeverri
Luz-Dary Gutiérrez-Castañeda
Fabio Sierra-Matamoros
Stephania Navarrete
Anggie Aparicio
Luis Saenz

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.894577

3,590 views
6 citations

Original Research

Published on 05 Jul 2022

Estrogen Mediates an Atherosclerotic-Protective Action via Estrogen Receptor Alpha/SREBP-1 Signaling

in Lipids in Cardiovascular Disease

Fei Xie
Xiandong Li
Yue Xu
Dongliang Cheng
Xianru Xia
Xi Lv
Guolin Yuan
Chunyan Peng

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.895916

4,336 views
9 citations

Original Research

Published on 04 Jul 2022

Differential Effects of Genetically Determined Cholesterol Efflux Capacity on Coronary Artery Disease and Ischemic Stroke

in Lipids in Cardiovascular Disease

Aoming Jin
Mengxing Wang
Weiqi Chen
Hongyi Yan
Xianglong Xiang
Yuesong Pan

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.891148

2,199 views

Navigation group

Articles

Case report: Unusual coexistence between familial hypercholesterolemia and familial hypobetalipoproteinemia

Treatment patterns and use of healthcare resources of patients with atherosclerotic cardiovascular disease and hypercholesterolemia and patients with familial hypercholesterolemia in Spain: Protocol of the Reality study

The relationship of remnant cholesterol and abdominal obesity in children: A cross-sectional study

Trajectory of low-density lipoprotein cholesterol in patients with chronic kidney disease and its association with cardiovascular disease

An intensive, structured, mobile devices-based healthcare intervention to optimize the lipid-lowering therapy improves lipid control after an acute coronary syndrome

Optimized Treatment of Refractory Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia With Alirocumab (OPTIMIZE)

Editorial: Insights in lipids in cardiovascular disease: 2021

Using Synthetic ApoC-II Peptides and nAngptl4 Fragments to Measure Lipoprotein Lipase Activity in Radiometric and Fluorescent Assays

Antiphospholipid Syndrome-Related Pulmonary Embolism: Clinical Characteristics and Early Recognition

Dyslipidemia and the Prevalence of Hypertension: A Cross-Sectional Study Based on Chinese Adults Without Type 2 Diabetes Mellitus

U-Shaped Relationship of Non-HDL Cholesterol With All-Cause and Cardiovascular Mortality in Men Without Statin Therapy

Corrected Serum Ionized Calcium as a Risk Factor Related to Adult Dyslipidemia

Risk Factors and Outcomes of Acute Myocardial Infarction in a Cohort of Antiphospholipid Syndrome

Vascular Age, Metabolic Panel, Cardiovascular Risk and Inflammaging in Patients With Rheumatoid Arthritis Compared With Patients With Osteoarthritis

Estrogen Mediates an Atherosclerotic-Protective Action via Estrogen Receptor Alpha/SREBP-1 Signaling

Differential Effects of Genetically Determined Cholesterol Efflux Capacity on Coronary Artery Disease and Ischemic Stroke